Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk as the drugmaker hunts for a ...

Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk , after the company lost its first mover ...

A media report stated that an activist investor is accumulating a stake in the Wegovy maker. Wegovy and Ozempic maker Novo ...

This update covers current health news, focusing on Parvus Asset Management's influence on Novo Nordisk's CEO selection, ...

Parvus Asset Management, a London-based activist hedge fund, is acquiring a stake in Danish pharmaceutical company Novo Nordisk (NYSE: NVO), according to The Fina ...

The current health news highlights a series of dynamic events, including Parvus Asset Management's stake in Novo Nordisk, WHO ...

European stocks were steady on Tuesday, shrugging off modest losses from the previous session, as investors stayed on edge ...

Moelis threw himself into action, developing a reputation as one of the best connected bankers on Wall Street. In 2014, Moelis & Company went public and it now has a market capitalisation of more than ...

Ryanair Holdings ( ($RYAAY) ) has issued an announcement. On June 2, 2025, Ryanair Holdings Plc was notified of a significant change in the ...